BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 29588403)

  • 1. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
    Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
    Sugui JA; Peterson SW; Clark LP; Nardone G; Folio L; Riedlinger G; Zerbe CS; Shea Y; Henderson CM; Zelazny AM; Holland SM; Kwon-Chung KJ
    J Clin Microbiol; 2012 Oct; 50(10):3309-17. PubMed ID: 22855513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Olorofim (F901318) against
    Seyedmousavi S; Chang YC; Law D; Birch M; Rex JH; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed characterisation of invasive aspergillosis in a murine model of X-linked chronic granulomatous disease shows new insights in infections caused by
    King J; Dambuza IM; Reid DM; Yuecel R; Brown GD; Warris A
    Front Cell Infect Microbiol; 2023; 13():1241770. PubMed ID: 37724291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus.
    Dotis J; Roilides E
    Int J Infect Dis; 2004 Mar; 8(2):103-10. PubMed ID: 14732328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
    Bianchi M; Niemiec MJ; Siler U; Urban CF; Reichenbach J
    J Allergy Clin Immunol; 2011 May; 127(5):1243-52.e7. PubMed ID: 21376380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis.
    Gresnigt MS; Becker KL; Leenders F; Alonso MF; Wang X; Meis JF; Bain JM; Erwig LP; van de Veerdonk FL
    J Innate Immun; 2018; 10(2):145-160. PubMed ID: 29248928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from Cryptococcus gattii Independently of T Cells.
    Davis MJ; Moyer S; Hoke ES; Sionov E; Mayer-Barber KD; Barber DL; Cai H; Jenkins L; Walter PJ; Chang YC; Kwon-Chung KJ
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213551
    [No Abstract]   [Full Text] [Related]  

  • 9. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
    Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
    Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease.
    Petersen JE; Hiran TS; Goebel WS; Johnson C; Murphy RC; Azmi FH; Hood AF; Travers JB; Dinauer MC
    J Invest Dermatol; 2002 Mar; 118(3):424-9. PubMed ID: 11874480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis.
    Shigemura T; Nakazawa Y; Yoshikawa K; Hirabayashi K; Saito S; Kobayashi N; Sakashita K; Shiohara M; Wada T; Shimodaira S; Agematsu K; Koike K
    Transfusion; 2014 Mar; 54(3):516-21. PubMed ID: 23808662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease.
    Chang YC; Segal BH; Holland SM; Miller GF; Kwon-Chung KJ
    J Clin Invest; 1998 May; 101(9):1843-50. PubMed ID: 9576747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature.
    Dotis J; Roilides E
    Mycoses; 2011 Nov; 54(6):e686-96. PubMed ID: 21615532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.
    Sionov E; Mayer-Barber KD; Chang YC; Kauffman KD; Eckhaus MA; Salazar AM; Barber DL; Kwon-Chung KJ
    PLoS Pathog; 2015 Aug; 11(8):e1005040. PubMed ID: 26252005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.
    De Luca A; Iannitti RG; Bozza S; Beau R; Casagrande A; D'Angelo C; Moretti S; Cunha C; Giovannini G; Massi-Benedetti C; Carvalho A; Boon L; Latgé JP; Romani L
    J Clin Invest; 2012 May; 122(5):1816-31. PubMed ID: 22523066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Reactive Oxygen Species Enhance Alveolar Macrophage Activity against Aspergillus fumigatus but Are Dispensable for Host Protection.
    Shlezinger N; Hohl TM
    mSphere; 2021 Jun; 6(3):e0026021. PubMed ID: 34077261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy.
    Cruz CR; Lam S; Hanley PJ; Bear AS; Langston C; Cohen AJ; Liu H; Martinez CA; Krance RA; Heslop HE; Rooney CM; Hanson IC; Bollard CM
    Clin Exp Immunol; 2013 Oct; 174(1):89-96. PubMed ID: 23763437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease.
    Henriet SS; Jans J; Simonetti E; Kwon-Chung KJ; Rijs AJ; Hermans PW; Holland SM; de Jonge MI; Warris A
    J Infect Dis; 2013 Jun; 207(12):1932-9. PubMed ID: 23482646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Characterization of Clinical Isolates of the Opportunistic Fungal Pathogen Aspergillus nidulans.
    Bastos RW; Valero C; Silva LP; Schoen T; Drott M; Brauer V; Silva-Rocha R; Lind A; Steenwyk JL; Rokas A; Rodrigues F; Resendiz-Sharpe A; Lagrou K; Marcet-Houben M; Gabaldón T; McDonnell E; Reid I; Tsang A; Oakley BR; Loures FV; Almeida F; Huttenlocher A; Keller NP; Ries LNA; Goldman GH
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269156
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspergillus nidulans infection in chronic granulomatous disease.
    Segal BH; DeCarlo ES; Kwon-Chung KJ; Malech HL; Gallin JI; Holland SM
    Medicine (Baltimore); 1998 Sep; 77(5):345-54. PubMed ID: 9772923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.